Author

Adam A. Moverley

Primary ORCID profile (0009-0007-1816-3317 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Adam A. MoverleyiD2 papers · Agency for Science, Technology and Research

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:multiome· 1

Frequent Co-Authors

Chenchen Li· 1 shared Douglas C. WallaceiD· 1 shared Jian HuangiD· 1 shared Kevin Janssen· 1 shared Kristen W. LynchiD· 1 shared Martin P. CarrolliD· 1 shared Mathieu Quesnel-VallièresiD· 1 shared Nicolas Skuli· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chenchen Li

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJun 25, 2023

A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies

Xiaolei Liu, Sudhish A. Devadiga, Robert F. Stanley…·Peter S. Klein

This study shows that SRSF2 mutations disrupt mitochondrial mRNA splicing, impair complex I function, and increase mitophagy through a PINK1 splicing mechanism, identifying mitophagy as a therapeutic target in MDS and AML.

DOI 10.1101/2023.06.25.546449

𝕏 PostBluesky